Association of Community Cancer Centers

The Association of Community Cancer Centers today announced the launch of the ACCC Community Oncology Research Institute.

At a panel at the ACCC 47th Annual Meeting and Cancer Center Business Summit, several oncology professionals discussed the many changes to cancer care that COVID-19 has accelerated and what challenges still lie ahead.

Robert Coleman, MD, FACOG, FACS, discusses the research model he utilizes to bring more patient research to the lung cancer field, a topic he presented on during the Association of Community Cancer Centers Annual Meeting.

The Association of Community Cancer Centers urged the Centers for Medicare and Medicaid Services to withdraw from The Most Favored Nation Model Interim Final Rule with Comment Period due to fears of the disproportionate impact the model could have on cancer care.

James Hamrick, MD, senior medical director, Flatiron Health, discusses how clinical trials can be improved in the community setting during the ACCC 44th Annual Meeting & Cancer Center Business Summit.

Mark S. Soberman, MD, MBA, FACS, 2017-2018 president of the Association of Community Cancer Centers (ACCC), discusses various approaches that can be used to integrate multidisciplinary healthcare programs into various healthcare settings, following a panel discussion during the ACCC 44th Annual Meeting & Cancer Center Business Summit.

Perspectives from the community, academic, and scientific settings came together during a panel discussion on precision medicine and genetic testing in the community setting at the Association of Community Cancer Centers’ 44th Annual Meeting and Cancer Center Business Summit.

Lawrence D. Wagman, MD, FACS, executive medical director of St. Joseph&rsquo;s Hospital, discusses the future of precision medicine and genetic testing in the community.<br /> &nbsp;

In a panel discussion this morning during the&nbsp;Association of Community Cancer Center (ACCC)&rsquo;s 44th Annual Meeting &amp; Cancer Center Business Summit,&nbsp;experts stressed the importance of integrating team-based care to break silos and allow a continued care transition as the move continues toward value-based care.

Financial toxicity is increasingly recognized as an adverse event of modern oncologic treatment.&nbsp;In recognition of the need to guide patients through this aspect of their cancer journey, the Association of Community Cancer Centers has unveiled Financial Advocacy Services Guidelines 2018.

James Hamrick, MD, MPH,&nbsp;discusses improving patient accrual and managing clinical trials in the community setting.

During a panel at&nbsp;the Association for Community Cancer Center 44th Annual Meeting &amp; Cancer Center Business Summit this morning, experts discussed some of the biggest drivers of change in oncology care, as well as what is in need of the most attention at the present time.

Experts discusses who will establish quality standards in the new value landscape during the&nbsp;44th Annual Meeting and Cancer Center Business Summit of the Association of Community Cancer Centers.

Catherine Fine, MS, Certified Genetic Counselor, lead, Clinical Cancer Services at Genome Medical, discusses questions on genetic counseling in the community setting.